A clinical formulation indicated for Weight Loss. Utilization supports appetite regulation and aids in managing metabolic consistency for those pursuing long-term health objectives.
Designed to support weight reduction by targeting appetite centers to address cravings and alleviate caloric intake in obese or overweight adults.
Mechanism of Action
Contrave combines two medications that work on the reward system and hunger signals in the brain. It acts on the hypothalamus and the mesolimbic dopamine circuit to reduce food cravings and increase the feeling of fullness.
Route of Administration
Oral
Onset Time
2–4 weeks for initial effect
Duration
12–24 hours
Contraindications
History of seizures, Uncontrolled hypertension, Eating disorders, Chronic opioid use, Recent MAOI use
Severe Adverse Events
Suicidal thoughts, Seizures, Severe liver damage, Severe hypertension, Angle-closure glaucoma
Common Side Effects
Mild nausea, Headache, Dry mouth
Uncommon Side Effects
Constipation, Dizziness, Insomnia, Anxiety
Drug Interactions
Opioids, MAOIs, Alcohol, Digoxin, Ritonavir
Pregnancy Safety Warnings
Not recommended; weight loss offers no benefit during pregnancy.
Age Restrictions
For adults only.
Storage Guidelines
Store at room temperature away from sunlight and moisture.
Information for Contrave is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
